These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2887553)

  • 1. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
    McEvoy JP
    J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic effects on memory: benztropine versus amantadine.
    Gelenberg AJ; Van Putten T; Lavori PW; Wojcik JD; Falk WE; Marder S; Galvin-Nadeau M; Spring B; Mohs RC; Brotman AW
    J Clin Psychopharmacol; 1989 Jun; 9(3):180-5. PubMed ID: 2661606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.
    Hitri A; Craft RB; Fallon J; Sethi R; Sinha D
    Psychopharmacol Bull; 1987; 23(1):33-7. PubMed ID: 2885890
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.
    McEvoy JP; McCue M; Spring B; Mohs RC; Lavori PW; Farr RM
    Am J Psychiatry; 1987 May; 144(5):573-7. PubMed ID: 3578566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755
    [No Abstract]   [Full Text] [Related]  

  • 7. Amantadine in drug-induced extrapyramidal signs: a comparative study.
    Ananth J; Sangani H; Noonan JP
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):323-6. PubMed ID: 239908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.
    Fayen M; Goldman MB; Moulthrop MA; Luchins DJ
    Am J Psychiatry; 1988 Apr; 145(4):483-6. PubMed ID: 2894780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
    Hitri A; Craft RB; Sethi R; Sinha D
    Clin Neuropharmacol; 1987 Jun; 10(3):261-71. PubMed ID: 2900683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticholinergic effects on memory: benztropine vs. amantadine.
    Van Putten T; Gelenberg AJ; Lavori PW; Falk WE; Marder SR; Spring B; Mohs RC; Brotman AW
    Psychopharmacol Bull; 1987; 23(1):26-9. PubMed ID: 3602326
    [No Abstract]   [Full Text] [Related]  

  • 13. Meige syndrome: relief on high-dose anticholinergic therapy.
    Duvoisin RC
    Clin Neuropharmacol; 1983 Mar; 6(1):63-6. PubMed ID: 6850651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication.
    Jellinek T
    Dis Nerv Syst; 1977 May; 38(5):353-5. PubMed ID: 852367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.
    Mori K; Yamashita H; Nagao M; Horiguchi J; Yamawaki S
    Pharmacopsychiatry; 2002 Jan; 35(1):6-11. PubMed ID: 11819152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
    Bukowczyk A; Wasik A; Horodnicki J
    Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.